Hikal Limited (BOM:524735)

Market Cap	51.42B
Revenue (ttm)	18.22B
Net Income (ttm)	746.02M
Shares Out	123.30M
EPS (ttm)	6.04
PE Ratio	69.01
Forward PE	52.78
Dividend	1.20 (0.29%)
Ex-Dividend Date	Feb 7, 2025

Volume	15,717
Average Volume	41,419
Open	432.60
Previous Close	431.45
Day's Range	421.90 - 436.60
52-Week Range	268.05 - 464.50
Beta	0.98
RSI	54.78
Earnings Date	May 9, 2025

About Hikal

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, wh...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 2,061
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524735

Financial Performance

In 2023, Hikal's revenue was 17.85 billion, a decrease of -11.79% compared to the previous year's 20.23 billion. Earnings were 696.02 million, a decrease of -11.20%.